drugset / Trial / NCT04382547
Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells
Phase 1/2
Completed
32 enrolled
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Belarusian State Medical University · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Treatment of patients with Covid-19 associated pneumonia using intravenous injection of allogenic pooled olfactory mucosa-derived mesenchymal stem cells
Timeline
- Start
- 2020-05-11
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogenic pooled olfactory mucosa-derived mesenchymal stem cells | Cell therapy | — | Intravenous |